https://doi.org/10.1186/s13046-022-02581-1
Y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
400
Citations
10
h-index
10
i10-index
Youqin Xu is an academic researcher from Second Affiliated Hospital of Guangzhou Medical University. The author has contributed to research in topics: RNA modifications and cancer & Ferroptosis and cancer prognosis & Epigenetics and DNA Methylation. The author has an h-index of 10, co-authored 13 publications.
ORCID: 0000-0001-6085-8736Papers by this author
worksThe N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer
2023 · Journal of Experimental & Clinical Cancer Research · 122 citations
The miR-1185-2-3p—GOLPH3L pathway promotes glucose metabolism in breast cancer by stabilizing p53-induced SERPINE1
2021 · Journal of Experimental & Clinical Cancer Research · 55 citations
https://doi.org/10.1186/s13046-020-01767-9
CT1-3, a novel magnolol-sulforaphane hybrid suppresses tumorigenesis through inducing mitochondria-mediated apoptosis and inhibiting epithelial mesenchymal transition
2020 · European Journal of Medicinal Chemistry · 23 citations
https://doi.org/10.1016/j.ejmech.2020.112441
Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinoma
2016 · Cancer Cell International · 21 citations
https://doi.org/10.1186/s12935-016-0286-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat